Geographic and age variations in mutational processes in colorectal cancer
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články
Grantová podpora
R01 ES032547
NIEHS NIH HHS - United States
U01 CA167551
NCI NIH HHS - United States
U01 CA290479
NCI NIH HHS - United States
Wellcome Trust - United Kingdom
R01 CA269919
NCI NIH HHS - United States
001
World Health Organization - International
PubMed
40267983
PubMed Central
PMC12221974
DOI
10.1038/s41586-025-09025-8
PII: 10.1038/s41586-025-09025-8
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- incidence MeSH
- kolorektální nádory * genetika epidemiologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- mikrosatelitní nestabilita MeSH
- mutace INDEL genetika MeSH
- mutace * genetika MeSH
- mutační rychlost MeSH
- mutageny metabolismus MeSH
- peptidy metabolismus MeSH
- polyketidy metabolismus MeSH
- senioři MeSH
- věk při počátku nemoci MeSH
- věkové faktory MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Argentina epidemiologie MeSH
- Brazílie epidemiologie MeSH
- Kolumbie epidemiologie MeSH
- Rusko epidemiologie MeSH
- Thajsko epidemiologie MeSH
- Názvy látek
- colibactin MeSH Prohlížeč
- mutageny MeSH
- peptidy MeSH
- polyketidy MeSH
Incidence rates of colorectal cancer vary geographically and have changed over time1. Notably, in the past two decades, the incidence of early-onset colorectal cancer, which affects individuals below 50 years of age, has doubled in many countries2-5. The reasons for this increase are unknown. Here we investigate whether mutational processes contribute to geographic and age-related differences by examining 981 colorectal cancer genomes from 11 countries. No major differences were found in microsatellite-unstable cancers, but variations in mutation burden and signatures were observed in the 802 microsatellite-stable cases. Multiple signatures, most with unknown aetiologies, exhibited varying prevalence in Argentina, Brazil, Colombia, Russia and Thailand, indicating geographically diverse levels of mutagenic exposure. Signatures SBS88 and ID18, caused by the bacteria-produced mutagen colibactin6,7, had higher mutation loads in countries with higher colorectal cancer incidence rates. SBS88 and ID18 were also enriched in early-onset colorectal cancers, being 3.3 times more common in individuals who were diagnosed before 40 years of age than in those over 70 years of age, and were imprinted early during colorectal cancer development. Colibactin exposure was further linked to APC driver mutations, with ID18 being responsible for about 25% of APC driver indels in colibactin-positive cases. This study reveals geographic and age-related variations in colorectal cancer mutational processes, and suggests that mutagenic exposure to colibactin-producing bacteria in early life may contribute to the increasing incidence of early-onset colorectal cancer.
2nd Faculty of Medicine Charles University and Motol University Hospital Prague Czech Republic
Biomedical Sciences Graduate Program University of California San Diego La Jolla CA USA
Cancer Ageing and Somatic Mutation Wellcome Sanger Institute Cambridge UK
Centre for Biodiversity Genomics University of Guelph Guelph Ontario Canada
Clinical Center ISCARE Prague Czech Republic
Clinical Epidemiology N N Blokhin National Medical Research Centre of Oncology Moscow Russia
Colon Cancer Reference Center A C Camargo Cancer Center Sao Paulo Brazil
Department of Bioengineering University of California San Diego La Jolla CA USA
Department of Cellular and Molecular Medicine University of California San Diego La Jolla CA USA
Department of Colorectal Oncology Surgery Barretos Cancer Hospital Barretos Brazil
Department of Endoscopy Barretos Cancer Hospital Barretos Brazil
Department of Environmental Epidemiology Nofer Institute of Occupational Medicine Łódź Poland
Department of Epidemiology A C Camargo Cancer Center Sao Paulo Brazil
Department of Genetics Universidade Federal do Rio Grande do Sul Porto Alegre Brazil
Department of Internal Medicine Faculty of Medicine Chiang Mai University Chiang Mai Thailand
Department of Pathology Anatomic Pathology Hospital de Clínicas de Porto Alegre Porto Alegre Brazil
Department of Pathology Barretos Cancer Hospital Barretos Brazil
Department of Pathology University Clinical Centre of Serbia Belgrade Serbia
Department of Surgery Faculty of Medicine Prince of Songkla University Hat Yai Thailand
Division of Cancer Epidemiology and Genetics National Cancer Institute Bethesda MD USA
Division of Cancer Genomics National Cancer Center Research Institute Chuo ku Japan
Evidence Synthesis and Classification Branch International Agency for Research on Cancer Lyon France
Genomic Epidemiology Branch International Agency for Research on Cancer Lyon France
Institute of Animal Physiology and Genetics Czech Academy of Science Libechov Czech Republic
Instituto de Medicina Traslacional e Ingeniería Biomédica Buenos Aires Argentina
International Organization for Cancer Prevention and Research Belgrade Serbia
Life and Health Sciences Research Institute School of Medicine Minho University Braga Portugal
Lunenfeld Tanenbaum Research Institute Sinai Health System Toronto Ontario Canada
Medical Genetics Service Hospital de Clínicas de Porto Alegre Porto Alegre Brazil
Molecular Oncology Research Center Barretos Cancer Hospital Barretos Brazil
Moores Cancer Center University of California San Diego La Jolla CA USA
National Cancer Institute Bangkok Thailand
Oncological Pathology Group Terry Fox National Tumor Bank National Cancer Institute Bogotá Colombia
Ontario Tumour Bank Ontario Institute for Cancer Research Toronto Ontario Canada
Parasites and Microbes Wellcome Sanger Institute Cambridge UK
Sanford Stem Cell Institute University of California San Diego La Jolla CA USA
The Maria Sklodowska Cure National Research Institute of Oncology Warsaw Poland
Zobrazit více v PubMed
Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. PubMed DOI
Siegel, R. L., Jemal, A. & Ward, E. M. Increase in incidence of colorectal cancer among young men and women in the United States. PubMed DOI
Vuik, F. E. et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. PubMed DOI PMC
Siegel, R. L. et al. Global patterns and trends in colorectal cancer incidence in young adults. PubMed DOI
Patel, S. G., Karlitz, J. J., Yen, T., Lieu, C. H. & Boland, C. R. The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. PubMed DOI
Lee-Six, H. et al. The landscape of somatic mutation in normal colorectal epithelial cells. PubMed DOI
Pleguezuelos-Manzano, C. et al. Mutational signature in colorectal cancer caused by genotoxic PubMed DOI PMC
Brennan, P. & Davey-Smith, G. Identifying novel causes of cancers to enhance cancer prevention: new strategies are needed. PubMed DOI PMC
Ames, B. N., Durston, W. E., Yamasaki, E. & Lee, F. D. Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. PubMed DOI PMC
Kucab, J. E. et al. A compendium of mutational signatures of environmental agents. PubMed DOI PMC
Moody, S. et al. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. PubMed DOI
Zhang, T. et al. Genomic and evolutionary classification of lung cancer in never smokers. PubMed DOI PMC
Senkin, S. et al. Geographic variation of mutagenic exposures in kidney cancer genomes. PubMed DOI PMC
Perdomo, S. et al. The Mutographs biorepository: A unique genomic resource to study cancer around the world. PubMed DOI PMC
Torrens, L. et al. The complexity of tobacco smoke-induced mutagenesis in head and neck cancer. PubMed DOI PMC
Stigliano, V., Sanchez-Mete, L., Martayan, A. & Anti, M. Early-onset colorectal cancer: a sporadic or inherited disease? PubMed DOI PMC
Spaander, M. C. W. et al. Young-onset colorectal cancer. PubMed DOI PMC
You, Y. N., Xing, Y., Feig, B. W., Chang, G. J. & Cormier, J. N. Young-onset colorectal cancer: is it time to pay attention? PubMed DOI
Venugopal, A. & Carethers, J. M. Epidemiology and biology of early onset colorectal cancer. PubMed PMC
The Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. PubMed DOI PMC
Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. PubMed DOI PMC
Degasperi, A. et al. Substitution mutational signatures in whole-genome-sequenced cancers in the UK population. PubMed DOI PMC
Cornish, A. J. et al. The genomic landscape of 2,023 colorectal cancers. PubMed DOI PMC
Priestley, P. et al. Pan-cancer whole-genome analyses of metastatic solid tumours. PubMed DOI PMC
Mendelaar, P. A. J. et al. Whole genome sequencing of metastatic colorectal cancer reveals prior treatment effects and specific metastasis features. PubMed DOI PMC
Martinez-Jimenez, F. et al. Pan-cancer whole-genome comparison of primary and metastatic solid tumours. PubMed DOI PMC
Rosendahl Huber, A. et al. Improved detection of colibactin-induced mutations by genotoxic PubMed DOI
Nunes, L. et al. Prognostic genome and transcriptome signatures in colorectal cancers. PubMed DOI PMC
Díaz-Gay, M. & Alexandrov, L. B. in PubMed
Helleday, T., Eshtad, S. & Nik-Zainal, S. Mechanisms underlying mutational signatures in human cancers. PubMed DOI PMC
Pich, O. et al. The mutational footprints of cancer therapies. PubMed DOI PMC
Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. PubMed DOI PMC
Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. PubMed DOI PMC
Islam, S. M. A. et al. Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. PubMed DOI PMC
Alexandrov, L. B. et al. Clock-like mutational processes in human somatic cells. PubMed DOI PMC
Gerstung, M. et al. The evolutionary history of 2,658 cancers. PubMed DOI PMC
Dentro, S. C. et al. Characterizing genetic intra-tumor heterogeneity across 2,658 human cancer genomes. PubMed DOI PMC
Chen, B. et al. Contribution of PubMed DOI PMC
Martinez-Jimenez, F. et al. A compendium of mutational cancer driver genes. PubMed DOI
Kim, J. E. et al. High prevalence of PubMed DOI PMC
Díaz-Gay, M. et al. Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment. PubMed DOI PMC
Terlouw, D. et al. Recurrent APC splice variant c.835-8A>G in patients with unexplained colorectal polyposis fulfilling the colibactin mutational signature. PubMed DOI
Fearon, E. R. & Vogelstein, B. A genetic model for colorectal tumorigenesis. PubMed DOI
Carethers, J. M. & Jung, B. H. Genetics and genetic biomarkers in sporadic colorectal cancer. PubMed DOI PMC
Perdomo, S. Mutational signatures in five cancer types across five continents. Standard operating procedures (SOPs).
Harris, P. A. et al. Research electronic data capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. PubMed DOI PMC
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. PubMed DOI PMC
Whalley, J. P. et al. Framework for quality assessment of whole genome cancer sequences. PubMed DOI PMC
Bergmann, E. A., Chen, B. J., Arora, K., Vacic, V. & Zody, M. C. Conpair: concordance and contamination estimator for matched tumor-normal pairs. PubMed DOI PMC
Kim, S. et al. Strelka2: fast and accurate calling of germline and somatic variants. PubMed DOI
Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. PubMed DOI PMC
Van Loo, P. et al. Allele-specific copy number analysis of tumors. PubMed DOI PMC
Nik-Zainal, S. et al. The life history of 21 breast cancers. PubMed DOI PMC
Jones, D. et al. cgpCaVEManWrapper: simple execution of CaVEMan in order to detect somatic single nucleotide variants in NGS data. PubMed DOI PMC
Raine, K. M. et al. cgpPindel: identifying somatically acquired insertion and deletion events from paired end sequencing. PubMed DOI PMC
Chen, X. et al. Manta: rapid detection of structural variants and indels for germline and cancer sequencing applications. PubMed DOI
Bergstrom, E. N. et al. SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events. PubMed DOI PMC
Khandekar, A. et al. Visualizing and exploring patterns of large mutational events with SigProfilerMatrixGenerator. PubMed DOI PMC
Gilson, P. et al. Evaluation of 3 molecular-based assays for microsatellite instability detection in formalin-fixed tissues of patients with endometrial and colorectal cancers. PubMed DOI PMC
Liu, M., Wu, Y., Jiang, N., Boot, A. & Rozen, S. G. mSigHdp: hierarchical Dirichlet process mixture modeling for mutational signature discovery. PubMed DOI PMC
Alexandrov, L. B., Nik-Zainal, S., Wedge, D. C., Campbell, P. J. & Stratton, M. R. Deciphering signatures of mutational processes operative in human cancer. PubMed DOI PMC
Steele, C. D. et al. Signatures of copy number alterations in human cancer. PubMed DOI PMC
Everall, A. et al. Comprehensive repertoire of the chromosomal alteration and mutational signatures across 16 cancer types from 10,983 cancer patients. Preprint at
Sondka, Z. et al. COSMIC: a curated database of somatic variants and clinical data for cancer. PubMed DOI PMC
Senkin, S. MSA: reproducible mutational signature attribution with confidence based on simulations. PubMed DOI PMC
Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. PubMed DOI PMC
Sondka, Z. et al. The COSMIC Cancer Gene Census: describing genetic dysfunction across all human cancers. PubMed DOI PMC
Chakravarty, D. et al. OncoKB: a precision oncology knowledge base. PubMed PMC
Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. PubMed DOI PMC
Muiños, F., Martinez-Jimenez, F., Pich, O., Gonzalez-Perez, A. & Lopez-Bigas, N. In silico saturation mutagenesis of cancer genes. PubMed DOI
Cheng, J. et al. Accurate proteome-wide missense variant effect prediction with AlphaMissense. PubMed DOI
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate—a practical and powerful approach to multiple testing. DOI
Goncearenco, A. et al. Exploring background mutational processes to decipher cancer genetic heterogeneity. PubMed DOI PMC
Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. PubMed DOI PMC
Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. PubMed DOI PMC
Liao, W. W. et al. A draft human pangenome reference. PubMed DOI PMC
Gu, Z., Gu, L., Eils, R., Schlesner, M. & Brors, B. circlize Implements and enhances circular visualization in R. PubMed DOI
Mansournia, M. A., Geroldinger, A., Greenland, S. & Heinze, G. Separation in logistic regression: causes, consequences, and control. PubMed DOI